Advertisement

Topics

Companies Related to "TapImmune Amends Phase Clinical Trial Focus Larger Population" [Most Relevant Company Matches] RSS

11:52 EDT 24th September 2017 | BioPortfolio

Here are the most relevant search results for "TapImmune Amends Phase Clinical Trial Focus Larger Population" found in our extensive corporate database of over 50,000 company records.

Showing "TapImmune Amends Phase Clinical Trial Focus Larger Population" Companies 1–25 of 6,900+

Thursday 21st September 2017

FLX Bio, Inc.

FLX475 is a best-in-class oral, small molecule antagonist of CCR4. CCR4 ligands are elevated in multiple tumor types when compared to normal tissue. In preclinical studies, FLX475 inhibited tumor growth and increased tumor regression. In addition, FLX475 enhanced the antitumor effects of various checkpoint inhibitors including anti-PD-L1 and anti-CTLA4 ant...


Landos Biopharma, Inc.

Landos Biopharma, Inc. is an emerging biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases. Landos’ lead clinical asset, BT-11, is a novel, locally-acting small molecule targeting inflammatory bowel disease (IBD) that is expected to enter clinical testing for Crohn’s...

Wednesday 20th September 2017

Meyers & Flowers

Led by Illinois Super Lawyer and former President of the Illinois Trial Lawyers Association Peter J. Flowers, our team of experienced and creative trial attorneys & medical malpractice lawyers routinely take on large challenges, and succeed. In addition to representing clients locally in Chicago and nationally in a full spectrum of cases involving catastro...


DermOne Dermatology Associates of Texas, P.A.

DermOne Dermatology Associates of Texas provides comprehensive medical, surgical, and cosmetic dermatology services. Our physicians excel at treating the full spectrum of conditions of the skin, hair and nails. Their commitment is to provide patients with the safest, most effective treatments and an unparalleled patient experience. DermOne affiliated physi...

Celcuity Inc.

We are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. Our proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular activity dri...

Arcus Biosciences

Arcus Biosciences (“Arcus”) is a biotechnology company focused on the discovery and development of innovative cancer immunotherapies. Arcus was founded in 2015 by Terry Rosen and Juan Jaen, the co-founders of Flexus Biosciences, which in February 2015 was acquired by Bristol-Myers Squibb to access Flexus’s IDO inhibitor, which was in preclinical...

Tuesday 19th September 2017

Herbalife Nutrition

Herbalife Nutrition is a global nutrition company whose purpose is to make the world healthier and happier. We have been on a mission for nutrition - changing people's lives with great nutrition products & programs - since 1980. Together with our Herbalife Nutrition independent distributors, we are committed to providing solutions to the worldwide problems...

Raiven Healthcare

Providers use the Raiven Healthcare real-time, predictive analytics platform for complex health treatments, accessing the artificial intelligence (AI) tools to help determine the clinical treatment path that will deliver the best outcome at the optimum cost for a specific patient. The company’s groundbreaking technology has improved outcomes by 40% wh...

Monday 18th September 2017

Boehringer Ingelheim GmbH

Boehringer Ingelheim is a research-driven group of companies dedicated to researching, developing, manufacturing and marketing pharmaceuticals that improve health and quality of life.Our business consists of Prescription Medicines, Consumer Health Care and Animal Health. Activities grouped under Industrial Customer include Biopharmaceuticals and Chemicals.We focus on the production of innovative d...

Friday 15th September 2017

TissueTech Inc.

TissueTech, Inc., the parent company of Amniox Medical and Bio-Tissue, Inc., pioneered the development and clinical application of regenerative, amniotic tissue-based products. Amniox Medical markets products for use in the musculoskeletal and wound care markets; Bio-Tissue markets products for the ophthalmology and optometry markets. The National Institut...

Thursday 14th September 2017

U.S. Anesthesia Partners, Inc.

U.S. Anesthesia Partners is a single-specialty physician services organization that offers collaborative partnerships and practice management services to anesthesiologists. USAP identifies and collaborates with leading, quality groups of anesthesiologists who seek continued clinical autonomy, and a strategic partner with the resources and expertise to inve...

Summit Health Management

Founded in 2014, Summit Health Management (SHM) offers a physician-led, professionally-managed model of management services for Summit Medical Group in New Jersey and mid- to large-sized physician practices across the United States. Developed by physicians for physicians, SHM provides an innovative alternative to traditional options for the integration of ...

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. is a pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. The initial focus is on inhibitors of plasma kallikrein, which is an important component of the body’s inflammatory response and which, in excess, can l...

Wednesday 13th September 2017

MedLever, Inc.

MedLever radiation oncology applications simplify workflow, enhance patient engagement, and promote clinical excellence. The MedLever Platform was built to collect and organize high-quality clinical data. The MedLever Platform and its applications are used in radiation oncology departments and clinics in the US and Asia. MedLever applications allow for sea...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Lundbeck U.S.

Otsuka Pharmaceutical Company is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuka researches, develops, manufactures and markets innovative products, with a focus on pharmaceutical products to meet unmet medical needs and nutraceutical products for the maintenance o...

The Foundation for a Smoke-Free World

The Foundation for a Smoke-Free World is an independent, non-profit organization dedicated to accelerating global efforts to reduce deaths and harm from smoking, with the ultimate goal of eliminating smoking worldwide. The Foundation also supports populations who are disproportionately burdened by a rapid transition away from smoking, with an initial focus...

TM3 Therapeutics

TM3 Therapeutics is focused on novel treatments for neurodegenerative and metabolic diseases by developing unique metabolite replacement therapies. Our goal is to improve survival outcomes and quality of life of patients with rare, genetic neurological diseases that have limited or no treatment options. Our clinical development program specifically targets...

Tuesday 12th September 2017

Creative Pharmacist

Co-founded by a community pharmacist and a technology expert in 2008, Creative Pharmacist, developer of the STRAND® clinical platform, is the U.S. market leader in helping pharmacists launch clinical services within their community. They support community pharmacists across the country in engaging patients with chronic disease, such as diabetes, through...

American Veterinarian®

American Veterinarian®, a comprehensive clinical multimedia information platform with resources both online and in print, provides companion animal practitioners with comprehensive news and information designed to improve patient outcomes and positively impact the way veterinarians practice. In fulfilling our mission to provide a broader view of medicin...

EFFY

EFFY empowers hospitals, hospital systems and Integrated Delivery Networks to retrieve, review and compare massive amounts of operational, clinical and financial data across their total enterprise -- no matter the size, data incompatibility or platform complexity. Functioning as a permanent, protective 24/7 auditing and exception reporting “umbrella,” ...

VEP Healthcare, Inc.

VEP Healthcare began providing emergency medical management services in 1981. In the years since, the organization’s expertise has expanded into hospitalist services, intensive care, clinical decision units, telehealth, and surgicalist services. Today, the owners of VEP – the company’s physicians, advanced practice clinicians, and corporate ...

Friday 8th September 2017

Quidel

Quidel Corporation discovers, develops, manufactures and markets rapid immunodiagnostic products for point-of-care detection of human medical conditions and illnesses. These products provide simple, accurate and cost-effective diagnoses of acute and chronic conditions in the areas of reproductive and women's health, infectious diseases, gastrointestinal andautoimmune disorders. Quidel's products a...

Thursday 7th September 2017

InflaRx GmbH

InflaRx is a clinical-stage biopharmaceutical company focusing on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. The company is also developing addi...

Antidote Technologies Ltd

Antidote is a digital health company on a mission to accelerate the breakthroughs of new treatments by bridging the gap between medical research and the people who need it. In a world where 80% of clinical trials are delayed or closed due to lack of participants, Antidote use cutting-edge technology to match the right patients with the right trials. Antido...

NewLink Genetics Corporation

NewLink Genetics Corporation is a biopharmaceutical company developing novel drugs and functional genomics solutions with a primary focus on cancer.The successful completion of the Human Genome Project signals a new age in medical discovery centered on protein research. The rapidly growing knowledge base of the human genome provides an unprecedented opportunity to launch a revolutionary paradigm ...


More From BioPortfolio on "TapImmune Amends Phase Clinical Trial Focus Larger Population"

Quick Search
Advertisement
 

Corporate Database Quicklinks